Hisamitsu Pharmaceutical Co., Inc. provided consolidated earnings guidance for the year Ending February 29, 2024.  For the year, the company expects net sales of JPY 132,300 million, operating profit of JPY 11,800 million, profit attributable to owners of parent JPY 10,600 million and basic earnings per share of JPY 133.60.